Wegovy linked to lower heart risks than similar drugs, study suggests

The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup